Log in Free sign up

Pfizer (PFE) News and press releases

News

From Benzinga Pro

As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster

Biotech, Large Cap, News, Health Care, FDA, Media, General

iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26

Biotech, Large Cap, News, Penny Stocks, Health Care, FDA, Legal, Management, IPOs, Top Stories, Tech, Media, General

Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years

Biotech, Large Cap, News, Health Care, FDA, General

Pfizer CEO Contracts COVID-19 Infection For Second Time

Biotech, Large Cap, News, Health Care, Media, General

Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said he had tested positive for COVID-19.

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges

Biotech, Large Cap, News, Health Care, Media, General

Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the booster in children six months through 5 years later this year.

Pfizer and BioNTech Submit Application To U.S. FDA For Emergency Use Authorization Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Children 5 Through 11 Years Of Age

Biotech, News, FDA, General

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a

Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna

Biotech, Large Cap, News, Health Care, Media, General

Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold

Biotech, Large Cap, News, Penny Stocks, Health Care, Small Cap, FDA, General

Pfizer, Sangamo Therapeutics Announce Phase 3 Trial Of Investigational Gene Therapy For Hemophilia A Has Re-Opened Recruitment

Pfizer and Sangamo Therapeutics announced that the Phase 3 AFFINE study evaluating giroctocogene fitelparvovec, an investigational gene therapy for patients with moderately severe to severe hemophilia A, has re-opened

10 Health Care Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Pfizer To Supply 6M COVID-19 Therapy Courses To Low Income Countries

Biotech, Large Cap, News, Health Care, General

'Pfizer AG Applies To Swissmedic For Authorisation Of A Second Bivalent Covid-19 Vaccine'

Biotech, News, General

https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/pfizer-stellt-zlgesuch-zweiten-bivalten-covid-19-impfstoff.html

This Is What Whales Are Betting On Pfizer

Options, Markets

A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 18 strange trades.

Analysts Put Alnylam On Upside Catalyst Watch Ahead Of Upcoming Data From Lead Program

Analyst Color, Biotech, Health Care, Price Target, Analyst Ratings, General

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 507 stocks hit new 52-week lows.

'New York City Lifting Covid-19 Vaccine Mandate For Private Sector' - Abc7NY

Biotech, News, General

https://abc7ny.com/nyc-covid-mask-mandate-new-york-statistics/12242966/?ex_cid=TA_WABC_TW&taid=6329c8841c8e330001002b70&utm_campaign=trueAnthem:+New+Content+(Feed)&utm_medium=trueAnthem&utm_source

Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer

Biotech, Large Cap, News, Health Care, Legal, Movers, Trading Ideas, General

Haleon Notified GSK and Pfizer that it Rejects their Requests for Indemnification Regarding Zantac

Haleon has notified GSK and Pfizer that it rejects their requests for indemnification on the basis that the scope of the indemnities set out in the joint venture agreement only covers their consumer healthcare businesses as conducted when the JV was formed in 2018. At that time, neither GSK nor Pfizer marketed OTC Zantac in the US or Canada.

Pfizer Shares Are Falling: What's Going On?

Movers, Trading Ideas

Pfizer Inc. (NYSE: PFE) shares are trading lower by 1.93% to $45.14 Monday afternoon. Shares of several vaccine companies at large are trading lower after President Biden in a '60 Minutes' interview said the Covid pandemic is over. What Else?

Stocks That Hit 52-Week Lows On Monday

On Monday, 429 stocks made new 52-week lows.

Press releases

From Benzinga Pro

Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age

NEW YORK and MAINZ, GERMANY, September 26, 2022 — Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency

Global Alopecia Treatment Market Report 2022: Industry Size, Share Growth and Forecast 2027

News, Press Releases

"Global Alopecia Treatment Market Report 2022: Industry Size, Share Growth and Forecast 2027"The global alopecia treatment market reached a value of US$ 3 Billion in 2021. Looking forward, IMARC Group expects the market

Pfizer Declares Fourth-Quarter 2022 Dividend

Board of Directors approves quarterly cash dividend of $0.40 per share Pfizer Inc. (NYSE:PFE) today announced that its board of directors declared a $0.40 fourth-quarter 2022 dividend on the company's common stock,

Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries

Treatment courses will be available for procurement by 132 Global Fund-eligible low-and-middle-income countries in all regions of the world beginning in 2022, subject to local regulatory approval or authorization The

Thinking about trading options or stock in Micron Technology, PayPal, Nvidia, Meta Platforms, or Pfizer?

Opinion, Press Releases

NEW YORK, Sept. 21, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MU, PYPL, NVDA, META, and PFE.

Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts

Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, November 1, 2022. The purpose of the call is to

Thinking about trading options or stock in Tesla, Wix, Lennar Corp, Pfizer, or Exxon Mobil?

Opinion, Press Releases

NEW YORK, Sept. 19, 2022LEN /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TSLA, WIX, LEN, PFE, and XOM.

Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union

Positive pivotal top-line data demonstrates 20-valent pneumococcal conjugate vaccine candidate (20vPnC), if approved, can likely help protect against all 20 vaccine serotypes in three-dose series and potentially offer

Thinking about buying stock in Esports Entertainment, AT&T, CSX Corp, Pfizer, or Dollar Tree?

Opinion, Press Releases

NEW YORK, Sept. 16, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GMBL, T, CSX, PFE, and DLTR.

Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union

Standard marketing authorization recommendation applies to all indications and formulations in the European Union, including COMIRNATY® Original/Omicron BA.4-5 and COMIRNATY® Original/Omicron BA.1 bivalent

Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents

Phase 3 trial demonstrates that the investigational pentavalent meningococcal vaccine (MenABCWY) was well-tolerated with an acceptable safety profile and immunogenicity non-inferior to Trumenba® + Menveo® for

Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine

First Phase 3 efficacy study to be conducted using an mRNA-based influenza vaccine; study will enroll 25,000 U.S. adults 18 years and older Influenza causes 140,000 to 710,000 hospitalizations and 12,000 to 52,000

Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer

Pfizer to provide therapeutics approved in late-stage cancer indications for new micrometastatic patient cohorts ANN ARBOR, Mich., Sept. 13, 2022 /PRNewswire/ -- Strata Oncology, Inc. a next-generation precision oncology

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union

CHMP recommendation based on favorable data from Omicron-adapted vaccinesThe Omicron BA.4/BA.5 bivalent COVID-19 booster vaccine combines 15-µg of mRNA encoding the wild-type spike protein of SARS-CoV-2 in the original

FDA and EMA Accept Regulatory Submission for Pfizer's Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata

– Filings based on clinical data demonstrating significant scalp hair regrowth versus placebo – Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug

Has The Controversy Around Falsified Alzheimer's Research Impacted The Path To Finding The Cure?

By Paul Henley, BenzingaVancouver, British Columbia, Canada--News Direct--Finding the cure to Alzheimer's has confounded researchers for decades.As a disease, Alzheimer's is highly complex and has a wide range of

FDA Grants Breakthrough Therapy Designation to Pfizer's Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration

ICON Releases its 2021 ESG Report

ICON plc, (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its 2021 Environmental, Social and Governance (ESG) Report. The report outlines how ICON is delivering

Global Vaccine Market Research Report 2022: Size, Share, Trends, Growth, Analysis, Revenue, and Forecast 2027

News, Press Releases

"Vaccine Market"The global vaccine market is expected to exhibit a CAGR of 10.33% during 2022-2027.The latest report by IMARC Group, titled “Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a discussion with William Pao, Chief Development Officer, Executive Vice President, and Aamir Malik, Chief Business